Concepedia

Author

M. Rinaldini

University of Cagliari

Also Known As

M. Rinaldini, Michela Rinaldini, S. Magnanini

14

Publications

863

Citations

7

H-Index

14

Concepts

All Affiliations

University of CagliariAzienda Usl 8 Arezzo
MR

About

M. Rinaldini is an author at University of Cagliari specializing in medicine, oncology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

358

2

Cancer Therapeutics

3

3

358

3

Pharmacology

2

2

258

4

Health Sciences

1

1

100

5

Cancer Epidemiology

1

1

100

M. Rinaldini

×

6

Publications

850

Citations

6

H-Index

YearCitations

Switching to Anastrozole Versus Continued Tamoxifen Treatment of Early Breast Cancer: Preliminary Results of the Italian Tamoxifen Anastrozole Trial

Francesco Boccardo, A. Rubagotti, Matteo Puntoni,

Journal of Clinical Oncology

2005

448

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial

Francesco Boccardo, A. Rubagotti, Pamela Guglielmini,

Annals of Oncology

2006

222

Switching to anastrozole (ANA) vs continued tamoxifen (TAM) treatment of early breast cancer (EBC). Updated results of the Italian tamoxifen anastrozole (ITA) trial

Francesco Boccardo, A. Rubagotti, Matteo Puntoni,

Journal of Clinical Oncology

2005

100

FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results

P Pacini, M. Rinaldini, R Algeri,

European Journal of Cancer

2000

36

Carboplatin and Vinorelbine in the Treatment of Advanced Non-Small-Cell Lung Cancer

Carmine Santomaggio, Enrico Tucci, M. Rinaldini,

American Journal of Clinical Oncology

1998

30

Conventional Versus High-Dose Epidoxorubicin as Single Agent in Advanced Breast Cancer

B Neri, P Pacini, R Algeri,

Cancer Investigation

1993

14

Page 1